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The mechanisms underlying rejection of
grafted neural tissue are still being defined.
Mechanisms relevant to genetically engineered
cells are of current interest. To date, attention
has focused on major histocompatibility complex
(MHC) antigens as targets of graft rejection. Yet
even when there is no MHC disparity, as when
the patient’s own cells are genetically altered,
there is still a potential for graft rejection,
directed against the novel antigens. We illustrate
this in a rat model.
METHODS
The 9L gliosarcoma line was made to express
E. coli-derived b-galactosidase (b-gal). The b-gal
is constitutively expressed as a cell-filling inter-
nal protein, revealed histochemically /1/. In
three experiments, syngeneic CDF hosts were
immunized with b-gal before intracerebral im-
plantation of b-gal + 9L cells. After three weeks,
the rats were sacrificed, and sections through the
brain were stained to reveal b-gal + cells. Con-
trols included rats immunized with other pro-
teins or unimmunized. For each brain, the slide
showing the most tumor was selected for
measurement of tumor area by image analysis.
RESULTS
In each experiment, immunization with b-gal
significantly reduced growth of the b-gal + cells.
For example, in one study the mean tumor areas
for control and b-gal immunized groups were,
respectively, 101 and 0.3 units2 (p<0.05,
Wilcoxon "sum of ranks" test).
DISCUSSION
We have developed an experimental model
that permits identification and quantitative anal-
ysis of individual transplanted cells, their
dissemination in the brain, and their interactions
with responding leukocytes/1/. The model was
used to illustrate that internal molecules can be
targets of graft rejection.
Our findings are consistent with current
understanding of T cell recognition. T cells
recognize [antigen+MHC proteins], not free
antigen. It is now appreciated that the
[antigen+MHC] complex is formed within the
cell. In different contexts, molecules synthesized
within the cell, or ingested molecules, may be
the antigen source. This suggests two ways by
which internal molecules could become targets
of graft rejection (Table I).
Host T cells may recognize [foreign antigen +
MHC] on transplanted cells with matchingMHC
phenotypes. Alternatively, host macrophages
may ingest foreign antigen, then present it, with
the macrophage’s own MHC, to host T cells.
TABLE 1
Internal molecules as target antigens
1. Direct attack of target cell. Antigen (AG) synthesized
within target cell. [MHC+AG] formed internally, then
expressed at surface.
2. Indirect attack. AG ingested by antigen-presenting cell
(APC), then expressed at surface with APC’s MHC.
Adjacent target cell killed as bystander.
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The resultant immune/inflammatory cascade
may lead to death of adjacent transplanted cells
as "bystanders". This indirect mechanism is of
particular interest where the transplanted cells
may not themselves express MHC antigens
(Lampson et al., this volume).
These findings draw attention to the potential
of internal molecules to serve as targets for graft
rejection, even when there is no MHC disparity.
They are relevant when the patient’s own cells
have been genetically modified to express novel
products.
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